SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-051397
Filing Date
2024-05-01
Accepted
2024-05-01 17:14:19
Documents
91
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q alks-20240331.htm   iXBRL 10-Q 1956533
2 EX-3.1 alks-ex3_1.htm EX-3.1 484262
3 EX-31.1 alks-ex31_1.htm EX-31.1 16220
4 EX-31.2 alks-ex31_2.htm EX-31.2 16235
5 EX-32.1 alks-ex32_1.htm EX-32.1 19099
6 GRAPHIC img77517403_0.jpg GRAPHIC 4907
7 GRAPHIC img77517403_1.jpg GRAPHIC 134869
8 GRAPHIC img77517403_2.jpg GRAPHIC 43283
9 GRAPHIC img77517403_3.jpg GRAPHIC 21082
  Complete submission text file 0000950170-24-051397.txt   10458957

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT alks-20240331.xsd EX-101.SCH 1452311
95 EXTRACTED XBRL INSTANCE DOCUMENT alks-20240331_htm.xml XML 1763461
Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000
Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000
Alkermes plc. (Filer) CIK: 0001520262 (see all company filings)

IRS No.: 981007018 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35299 | Film No.: 24904080
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)